Literature DB >> 2878117

Diabetes mellitus, atherosclerosis, and the 5' flanking polymorphism of the human insulin gene.

T Mandrup-Poulsen, D Owerbach, J Nerup, K Johansen, A Tybjaerg Hansen.   

Abstract

On the 5' side of the human insulin gene is a highly polymorphic locus containing 2 major size classes of DNA restriction fragments which segregate in families as stable genetic elements. Fragments with an average size of about 600 base-pairs (bp) (the 'L-allele') seem to be a weak genetic marker for type 1 (insulin-dependent) diabetes mellitus, whereas fragments of an average size of about 2500 bp (the 'U-allele') have hitherto been associated with type 2 (non-insulin-dependent) diabetes mellitus and diabetic hypertriglyceridaemia. Recent evidence does not confirm the association between the U-allele and type 2 diabetes. Our own studies suggest that the U-allele is a fairly strong marker for the development of atherosclerosis with a relative risk for U-carriers of 3.36. The U-allele has not been associated with conventional cardiovascular risk factors such as body weight, blood pressure, or levels of blood glucose, triglycerides or lipoproteins. The putative functions of the polymorphic region in the aetiology of type 1 diabetes and atherosclerosis, and the relation of this region to other genetic markers for these disorders are not known.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2878117     DOI: 10.1007/bf01800863

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  30 in total

1.  Islet beta-cell function and polymorphism in the 5'-flanking region of the human insulin gene.

Authors:  M A Permutt; P Rotwein; T Andreone; W K Ward; D Porte
Journal:  Diabetes       Date:  1985-04       Impact factor: 9.461

2.  Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction.

Authors:  G A Ferns; J Stocks; C Ritchie; D J Galton
Journal:  Lancet       Date:  1985-08-10       Impact factor: 79.321

3.  Polymorphism in the 5'-flanking region of the human insulin gene and its possible relation to type 2 diabetes.

Authors:  P Rotwein; R Chyn; J Chirgwin; B Cordell; H M Goodman; M A Permut
Journal:  Science       Date:  1981-09-04       Impact factor: 47.728

4.  Maturity onset diabetes of the young is not linked to the insulin gene.

Authors:  J I Bell; J S Wainscoat; J M Old; C Chlouverakis; H Keen; R C Turner; D J Weatherall
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-19

5.  Sequence of the human insulin gene.

Authors:  G I Bell; R L Pictet; W J Rutter; B Cordell; E Tischer; H M Goodman
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

6.  Insulin gene analysis in a family with maturity-onset diabetes of the young.

Authors:  T Andreone; S Fajans; P Rotwein; M Skolnick; M A Permutt
Journal:  Diabetes       Date:  1985-02       Impact factor: 9.461

7.  Possible association between DNA sequences flanking the insulin gene and atherosclerosis.

Authors:  D Owerbach; K Johansen; P Billesbølle; S Poulsen; M Schroll; J Nerup
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

8.  Analysis of the regions flanking the human insulin gene and sequence of an Alu family member.

Authors:  G I Bell; R Pictet; W J Rutter
Journal:  Nucleic Acids Res       Date:  1980-09-25       Impact factor: 16.971

9.  DNA sequences flanking the insulin gene on chromosome 11 confer risk of atherosclerosis.

Authors:  T Mandrup-Poulsen; D Owerbach; S A Mortensen; K Johansen; H Meinertz; H Sørensen; J Nerup
Journal:  Lancet       Date:  1984-02-04       Impact factor: 79.321

10.  Diabetic hypertriglyceridaemia and related 5' flanking polymorphism of the human insulin gene.

Authors:  N I Jowett; L G Williams; G A Hitman; D J Galton
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-14
View more
  1 in total

1.  Shared genetic susceptibility of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus: contributions of HLA and haptoglobin.

Authors:  S S Rich; S S Panter; F C Goetz; B Hedlund; J Barbosa
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.